Euclidean Capital as of Dec. 31, 2022
Portfolio Holdings for Euclidean Capital
Euclidean Capital holds 11 positions in its portfolio as reported in the December 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Ishares Tr Msci India Etf (INDA) | 22.5 | $24M | 577k | 41.74 | |
23andme Holding Class A Com (ME) | 20.7 | $22M | 10M | 2.16 | |
Pmv Pharmaceuticals (PMVP) | 19.0 | $20M | 2.3M | 8.70 | |
Alector (ALEC) | 8.5 | $9.1M | 981k | 9.23 | |
Rapt Therapeutics (RAPT) | 8.0 | $8.6M | 433k | 19.80 | |
Foghorn Therapeutics (FHTX) | 7.5 | $8.0M | 1.3M | 6.38 | |
Oric Pharmaceuticals (ORIC) | 4.1 | $4.4M | 748k | 5.89 | |
First Financial Ban (FFBC) | 3.9 | $4.2M | 174k | 24.23 | |
Ngm Biopharmaceuticals | 3.5 | $3.7M | 747k | 5.02 | |
Tenaya Therapeutics (TNYA) | 1.7 | $1.8M | 916k | 2.01 | |
Surrozen | 0.4 | $467k | 803k | 0.58 |